Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection

Front Immunol. 2022 Feb 18:13:859919. doi: 10.3389/fimmu.2022.859919. eCollection 2022.

Authors

Charles D Murin¹, Bronwyn M Gunn², Paul W H I Parren^{3

4}, Gary P Kobinger⁵

Affiliations

¹ Scripps Research, Department of Integrative Structural and Computational Biology, La Jolla, CA, United States.
² Paul G. Allen School of Global Health, Washington State University, Pullman, WA, United States.
³ Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.
⁴ Lava Therapeutics, Utrecht, Netherlands.
⁵ Galveston National Lab, Galveston, TX, United States.

No abstract available

Keywords: antibody therapeutic; ebolavirus; filovirus and viral hemorrhagic fever; monoclonal antibodies; vaccine.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Ebolavirus / immunology
Filoviridae
Hemorrhagic Fever, Ebola* / immunology
Hemorrhagic Fever, Ebola* / therapy
Humans